CandlesenseCandlesense
News/Companies/MLSS

MLSS News

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

MLSS

ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, August 15th, 2025, to discuss the company’s financial results for the second quarter ended June 30, 2025, as well as the company’s corporate progress and other developments.

August 13, 2025Earnings
Read more →

Milestone Scientific Q1 EPS $(0.02) Misses $(0.01) Estimate, Sales $2.23M Miss $2.43M Estimate

MLSS

May 15, 2025
Read more →

Milestone Scientific FY 2024 GAAP EPS $(0.06) Misses $(0.05) Estimate, Sales $8.630M Miss $9.261M Estimate

MLSS

April 15, 2025
Read more →

Benchmark Reiterates Speculative Buy on Milestone Scientific, Maintains $1.25 Price Target

MLSS

November 20, 2024
Read more →

Milestone Scientific Q3 EPS $(0.02) Misses $(0.01) Estimate, Sales $2.51M Miss $2.61M Estimate

MLSS

November 14, 2024
Read more →

Milestone Scientific Announces Arjan Haverhals Will Retire From His Role As CEO Of The Company On December 31, 2024; Neal Goldman, Chairman Of The Board, Has Been Appointed As Interim CEO

MLSS

November 14, 2024
Read more →

Milestone Scientific Q1 2024 GAAP EPS $(0.02), Inline, Sales $2.249M Miss $2.416M Estimate

MLSS

May 16, 2024
Read more →

Milestone Scientific's Return On Capital Employed Insights

MLSS

Benzinga Pro data, Milestone Scientific (AMEX:MLSS) reported Q2 sales of $1.65 million. Earnings fell to a loss of $2.88 million, resulting in a 50.13% decrease from last quarter.

September 13, 2022
Read more →